| Stage | PRKS | % of rev | DIS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $483M | 100.00% | $25.2B | 100.00% | DIS ×52.24 |
| Gross profit | $445M | 92.12% | $10.1B | 40.17% | PRKS +52.0pp |
| Operating income | $117M | 24.23% | $4.8B | 18.85% | PRKS +5.4pp |
| Pre-tax income | $85M | 17.52% | $3.6B | 14.44% | PRKS +3.1pp |
| Net income | $63M | 13.09% | $2.8B | 11.26% | PRKS +1.8pp |
| Stage | PRKS | DIS | Gap · A − B |
|---|---|---|---|
| Revenue | $483M100.00% | $25.2B100.00% | DIS ×52.24 |
| Gross profit | 92.12%$445M | 40.17%$10.1B | PRKS +52.0pp |
| Operating income | 24.23%$117M | 18.85%$4.8B | PRKS +5.4pp |
| Pre-tax income | 17.52%$85M | 14.44%$3.6B | PRKS +3.1pp |
| Net income |
| 13.09%$63M |
| 11.26%$2.8B |
| PRKS +1.8pp |
No shared counterparties.